No. Thirteen 28-day periods cover 364 days, while twelve cover only 336 days. A budget based on twelve four-week fills can therefore understate a continuous-supply scenario.
At an explicitly hypothetical fixed price of $350 per 28-day fill:
- Twelve fills cost $4,200.
- Thirteen fills cost $4,550.
- The difference is $350, or 8.33% of the twelve-fill budget.
This is arithmetic, not a prediction that a particular patient will require thirteen purchases or that an offer will remain unchanged.
Use a calendar-based model with actual fill dates, opening supply, discontinuations and carryover. Separate 28-day injectable packs, 30-day tablet supplies and longer dispensing periods. Manufacturer terms establish the relevant units for their offers. (zepbound.lilly.com)
Finance control: show both cash purchases during the year and supply attributable to the year.
Sources cited on this page
- zepbound.lilly.com · Source 1 ↗https://zepbound.lilly.com/hcp/coverage-savings